Cardio Diagnostics Holdings, Inc.

CDIOW
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001870144

Other share classesCDIO

Price chart

Open-market purchases and sales by CDIOW insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Oct 9, 20241:18 PM ETAmendedSep 6, 2024Dogan TimurChief Technology OfficerPPurchaseCommon Stock+68.97K$0.29+$20K197.31K+53.7%SEC
Oct 8, 202410:42 AM ETAmendedSep 6, 2024Dogan MeeshanthiniChief Executive OfficerPPurchaseCommon Stock+68.97K$0.29+$20K1.66M+4.3%SEC
Sep 10, 20245:22 PM ETSep 6, 2024Philibert RobertChief Medical OfficerPPurchaseCommon Stock+34.08K$0.2865+$9.76K1.68M+2.1%SEC
Sep 9, 202411:08 AM ETSep 6, 2024Dogan MeeshanthiniChief Technology OfficerPPurchaseCommon Stock+68.97K$0.29+$20K197.31K+53.7%SEC
Sep 9, 202411:01 AM ETSep 6, 2024Dogan MeeshanthiniChief Executive OfficerPPurchaseCommon Stock+68.97K$0.29+$20K1.68M+4.3%SEC

The largest institutional positions in CDIOW at the end of Q2 2026.

Institutions holding CDIOW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BOOTHBAY FUND MANAGEMENT, LLC60,540$132.58K0.00%00.0%Unchanged
Saba Capital Management, L.P.199,839$3K0.00%00.0%Unchanged
Clear Street Group Inc.82,342$1.5K0.00%00.0%Unchanged
D. E. Shaw & Co., Inc.74,822$1.36K0.00%00.0%Unchanged
Context Capital Management, LLC81,500$1.22K0.00%00.0%Unchanged